Michael Douglas

Medicine & Life Sciences

1. Multiple Sclerosis 100%
2. Axons 67%
3. Retinal Ganglion Cells 50%
4. Cerebrospinal Fluid 50%
5. Blood Platelets 49%
6. Immunoreceptor Tyrosine-Based Inhibition Motif 40%
7. Central Nervous System 38%
8. Megakaryocytes 37%
9. Regeneration 37%
10. Myelin Sheath 36%
11. Spinal Ganglia 33%
12. Neuronal Outgrowth 33%
13. opicinumab 30%
14. Growth 29%
15. Stromal Cells 28%
16. Apoptosis 27%
17. citron-kinase 26%
18. ErbB Receptors 26%
19. Neuroglia 26%
20. Non-Receptor Type 6 Protein Tyrosine Phosphatase 26%
21. phosphatidylinositol 3,5-diphosphate 23%
22. Nerve Growth Factors 23%
23. sialic acid receptor 23%
24. C-Type Lectins 21%
25. Primary Myelofibrosis 21%
26. Phospholipase C gamma 21%
27. Neurons 21%
28. Nervous System Trauma 20%
29. Tyrosine 20%
30. Actin Depolymerizing Factors 19%
31. Platelet Endothelial Cell Adhesion Molecule-1 19%
32. Immunoglobulin Light Chains 19%
33. src-Family Kinases 18%
34. RTKI cpd 18%
35. Spinal Injections 17%
36. Pericytes 17%
37. Heparitin Sulfate 17%
38. Guillain-Barre Syndrome 16%
39. Osmotic Pressure 16%
40. Survivin 16%
41. 4-hydroxy-5-nitrophenyl acetic acid 16%
42. Th1 Cells 16%
43. Vascular Cell Adhesion Molecule-1 16%
44. Diagnosis-Related Groups 15%
45. Metabolomics 15%
46. Parkinsonian Disorders 15%
47. Sedentary Behavior 15%
48. Integrins 14%
49. Green Fluorescent Proteins 14%
50. Apolipoproteins E 14%